Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 5, 2009 - Issue 1
Submit an article Journal homepage
500
Views
44
CrossRef citations to date
0
Altmetric
Review

Analytical strategies for the screening and evaluation of chemically reactive drug metabolites

Bo Wen Department of Drug Metabolism and Pharmacokinetics, Roche Palo Alto, Palo Alto, 94304 CA, USA +1 650 855 5463; +1 650 852 1070; [email protected]
&
William L Fitch Department of Drug Metabolism and Pharmacokinetics, Roche Palo Alto, Palo Alto, 94304 CA, USA +1 650 855 5463; +1 650 852 1070; [email protected]
Pages 39-55 | Published online: 23 Dec 2008

Bibliography

  • Fieser LF. Carcinogenic activity, structure and chemical reactivity of polynuclear aromatic hydrocarbons. Am J Cancer 1938;34:37-124
  • Miller EC, Miller JA. The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res 1947;7:468-80
  • Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. Chem Res Toxicol 2004;17:3-16
  • Williams DP. Toxicophores: investigations in drug safety. Toxicology 2006;226:1-11
  • Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2008;21:84-92
  • Liebler DC, Guengerich FP. Elucidating mechanisms of drug-induced toxicity. Nat Rev Drug Discov 2005;4(5):410-20
  • Nelson SD. Structure toxicity relationships – How useful are they in predicting toxicities of new drugs. In: Dansette PM, Delaforge RSM, Gibson GG, et al., Editors, Biological Reactive Intermediates, Kluwer Academic/Plenum Publishers, New York: 2001;6. p. 33-43
  • Walgren JL, Mitchell MD, Thompson DC. Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol 2005;35:325-61
  • Evans DC, Baillie TA. Minimizing the potential for metabolic activation as an integral part of drug design. Curr Opin Drug Discov Devel 2005;8:44-50
  • Kumar S, Kassahun K, Tschirret-Guth RA, et al. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions. Curr Opin Drug Discov Devel 2008;11:43-52
  • Kalgutkar AS, Soglia JR. Minimising the potential for metabolic activation in drug discovery. Expert Opin Drug Metab Toxicol 2005;1:91-142
  • Doss GA, Baillie TA. Addressing metabolic activation as an integral component of drug design. Drug Metab Rev 2006;38:641-9
  • Gibson JD, Pumford NR, Samokyszyn VM, Hinson JA. Mechanism of acetaminophen-induced hepatotoxicity: covalent binding versus oxidative stress. Chem Res Toxicol 1996;9:580-5
  • Hinson JA, Reid AB, Mccullough SS, James LP. Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev 2004;36:805-22
  • Takakusa H, Masumoto H, Yukinaga H, et al. Covalent binding and tissue distribution/retention assessment of drugs associated with idiosyncratic drug toxicity. Drug Metab Dispos 2008;36:1770-9
  • Soglia JR, Harriman SP, Zhao S, et al. The development of a higher throughput reactive intermediate screening assay incorporating micro-bore liquid chromatography-micro-electrospray ionization-tandem mass spectrometry and glutathione ethyl ester as an in vitro conjugating agent. J Pharm Biomed Anal 2004;36:105-16
  • Erve JC, Vashishtha SC, Demaio W, Talaat RE. Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry. Drug Metab Dispos 2007;35:908-16
  • Zhang KE, Naue JA, Arison B, Vyas KP. Microsomal metabolism of the 5-lipoxygenase inhibitor L-739,010: evidence for furan bioactivation. Chem Res Toxicol 1996;9:547-54
  • Argoti D, Liang L, Conteh A, et al. Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS/MS). Chem Res Toxicol 2005;18:1537-44
  • Deterding LJ, Bhattacharjee S, Ramirez DC, et al. Top-down and bottom-up mass spectrometric characterization of human myoglobin-centered free radicals induced by oxidative damage. Anal Chem 2007;79:6236-48
  • Chen WG, Zhang C, Avery MJ, Fouda HG. Reactive metabolite screen for reducing candidate attrition in drug discovery. In Biological Reactive Intermediates. In: Dansette PM, Delaforge RSM, Gibson GG, et al., Editors, Kluwer Academic/Plenum Publishers: New York, 2001;6. p. 521-4
  • Ma S, Subramanian R. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry. J Mass Spectrom 2006;41:1121-39
  • Baillie TA, Pearson PG, Rashed MS, Howald WN. The use of mass spectrometry in the study of chemically-reactive drug metabolites. Application of MS/MS and LC/MS to the analysis of glutathione- and related S-linked conjugates of N-methylformamide. J Pharm Biomed Anal 1989;7:1351-60
  • Baillie TA, Davis MR. Mass spectrometry in the analysis of glutathione conjugates. Biol Mass Spectrom 1993;22:319-25
  • Dalvie DK, Kalgutkar AS, Khojasteh-Bakht SC, et al. Biotransformation reactions of five-membered aromatic heterocyclic rings. Chem Res Toxicol 2002;15:269-99
  • Kalgutkar AS, Gardner I, Obach RS, et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab 2005;6:161-225
  • Zhou S, Chan E, Duan W, et al. Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 2005;37:41-213
  • Boelsterli UA, Ho HK, Zhou S, Leow KY. Bioactivation and hepatotoxicity of nitroaromatic drugs. Curr Drug Metab 2006;7:715-27
  • Wen B, Coe KJ, Rademacher P, et al. Comparison of In Vitro Bioactivation of Flutamide and its Cyano Analogue: Evidence for Reductive Activation by Human NADPH: Cytochrome P450 Reductase. Chem Res Toxicol 2008;21:2393-406
  • Nassar AE, Kamel AM, Clarimont C. Improving the decision-making process in structural modification of drug candidates: reducing toxicity. Drug Discov Today 2004;9:1055-64
  • Caldwell GW, Yan Z. Screening for reactive intermediates and toxicity assessment in drug discovery. Curr Opin Drug Discov Devel 2006;9:47-60
  • Haroldsen PE, Reilly MH, Hughes H, et al. Characterization of glutathione conjugates by fast atom bombardment/tandem mass spectrometry. Biomed Environ Mass Spectrom 1988;15:615-21
  • Murphy CM, Fenselau C, Gutierrez PL. Fragmentation characteristic of glutathione conjugates activated by high-energy collisions. J Am Soc Mass Spectrom 1992;3:815-22
  • Dieckhaus CM, Fernandez-Metzler CL, King R, et al. Negative ion tandem mass spectrometry for the detection of glutathione conjugates. Chem Res Toxicol 2005;18:630-8
  • Yan Z, Caldwell GW. Stable-isotope trapping and high-throughput screenings of reactive metabolites using the isotope MS signature. Anal Chem 2004;76:6835-47
  • Yan Z, Maher N, Torres R, Huebert N. Use of a trapping agent for simultaneous capturing and high-throughput screening of both “soft” and “hard” reactive metabolites. Anal Chem 2007;79:4206-14
  • Mutlib A, Lam W, Atherton J, et al. Application of stable isotope labeled glutathione and rapid scanning mass spectrometers in detecting and characterizing reactive metabolites. Rapid Commun Mass Spectrom 2005;19:3482-92
  • Ma L, Wen B, Ruan Q, Zhu M. Rapid screening of glutathione-trapped reactive metabolites by linear ion trap mass spectrometry with isotope pattern-dependent scanning and postacquisition data mining. Chem Res Toxicol 2008;21:1477-83
  • Mahajan MK, Evans CA. Dual negative precursor ion scan approach for rapid detection of glutathione conjugates using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2008;22:1032-40
  • Wen B, Ma L, Nelson SD, Zhu M. High-throughput screening and characterization of reactive metabolites using polarity switching of hybrid triple quadrupole linear ion trap mass spectrometry. Anal Chem 2008;80:1788-99
  • Wen B, Ma L, Rodrigues AD, Zhu M. Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine. Drug Metab Dispos 2008;36:841-50
  • Wen B, Ma L, Zhu M. Bioactivation of the tricyclic antidepressant amitriptyline and its metabolite nortriptyline to arene oxide intermediates in human liver microsomes and recombinant P450s. Chem Biol Interact 2008;173:59-67
  • Wen B, Fitch WL. Screening and characterization of reactive metabolites using glutathione ethyl ester in combination with Q-trap mass spectrometry. J Mass Spectrom 2008 Aug 21 [Epub ahead of print]
  • Zheng J, Ma L, Xin B, et al. Screening and identification of GSH-trapped reactive metabolites using hybrid triple quadruple linear ion trap mass spectrometry. Chem Res Toxicol 2007;20:757-66
  • Bauman JN, Frederick KS, Sawant A, et al. Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. Drug Metab Dispos 2008;36:1016-29
  • Wagner S, Scholz K, Sieber M, et al. Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine. Anal Chem 2007;79:2918-26
  • Scholz K, Dekant W, Volkel W, Pahler A. Rapid detection and identification of N-acetyl-L-cysteine thioethers using constant neutral loss and theoretical multiple reaction monitoring combined with enhanced product-ion scans on a linear ion trap mass spectrometer. J Am Soc Mass Spectrom 2005;16:1976-84
  • Gopaul SV, Farrell K, Abbott FS. Gas chromatography/negative ion chemical ionization mass spectrometry and liquid chromatography/electrospray ionization tandem mass spectrometry quantitative profiling of N-acetylcysteine conjugates of valproic acid in urine: application in drug metabolism studies in humans. J Mass Spectrom 2000;35:698-704
  • Manyike PT, Kharasch ED, Kalhorn TF, Slattery JT. Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. Clin Pharmacol Ther 2000;67:275-82
  • Sanders M, Shipkova PA, Zhang H, Warrack BM. Utility of the hybrid LTQ-FTMS for drug metabolism applications. Curr Drug Metab 2006;7:547-55
  • Ding J, Sorensen CM, Zhang Q, et al. Capillary LC coupled with high-mass measurement accuracy mass spectrometry for metabolic profiling. Anal Chem 2007;79:6081-93
  • Peterman SM, Duczak N Jr, Kalgutkar AS, et al. Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements. J Am Soc Mass Spectrom 2006;17:363-75
  • Castro-Perez J, Plumb R, Liang L, Yang E. A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun Mass Spectrom 2005;19:798-804
  • Zhang H, Zhang D, Ray K. A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analyses. J Mass Spectrom 2003;38:1110-2
  • Zhu M, Ma L, Zhang D, et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab Dispos 2006;34:1722-33
  • Zhang H, Zhu M, Ray KL, et al. Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection. Rapid Commun Mass Spectrom 2008;22:2082-8
  • Zhu M, Ma L, Zhang H, Humphreys WG. Detection and structural characterization of glutathione-trapped reactive metabolites using liquid chromatography-high-resolution mass spectrometry and mass defect filtering. Anal Chem 2007;79:8333-41
  • Lim HK, Chen J, Cook K, et al. A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom 2008;22:1295-311
  • Zhang H, Yang Y. An algorithm for thorough background subtraction from high-resolution LC/MS data: application for detection of glutathione-trapped reactive metabolites. J Mass Spectrom 2008;43:1181-90
  • Zhang H, Ma L, He K, Zhu M. An algorithm for thorough background subtraction from high-resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine. J Mass Spectrom 2008;43:1191-200
  • Guengerich FP, MacDonald JS. Applying mechanisms of chemical toxicity to predict drug safety. Chem Res Toxicol 2007;20:344-69
  • Baillie TA. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. Chem Res Toxicol 2008;21:129-37
  • Baillie TA. Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology. Chem Res Toxicol 2006;19:889-93
  • Hartman NR, Cysyk RL, Bruneau-Wack C, et al. Production of intracellular 35S-glutathione by rat and human hepatocytes for the quantification of xenobiotic reactive intermediates. Chem Biol Interact 2002;142:43-55
  • Thompson DC, Perera K, London R. Quinone methide formation from para isomers of methylphenol (cresol), ethylphenol, and isopropylphenol: relationship to toxicity. Chem Res Toxicol 1995;8:55-60
  • Gorrod JW, Whittlesea CM, Lam SP. Trapping of reactive intermediates by incorporation of 14C-sodium cyanide during microsomal oxidation. Adv Exp Med Biol 1991;283:657-64
  • Gorrod JW, Whittlesea CM, Lam SP. A quantitative high-throughput trapping assay as a measurement of potential for bioactivation. Anal Biochem 2006;351:266-72
  • Gan J, Harper TW, Hsueh MM, et al. Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites. Chem Res Toxicol 2005;18:896-903
  • Soglia JR, Contillo LG, Kalgutkar AS, et al. A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues. Chem Res Toxicol 2006;19:480-90
  • Hop CE. Use of nano-electrospray for metabolite identification and quantitative absorption, distribution, metabolism and excretion studies. Curr Drug Metab 2006;7:557-63
  • Hop CE, Chen Y, Yu LJ. Uniformity of ionization response of structurally diverse analytes using a chip-based nanoelectrospray ionization source. Rapid Commun Mass Spectrom 2005;19:3139-42
  • Wickremsinhe ER, Singh G, Ackermann BL, et al. A review of nanoelectrospray ionization applications for drug metabolism and pharmacokinetics. Curr Drug Metab 2006;7:913-28
  • Valaskovic GA, Utley L, Lee MS, Wu JT. Ultra-low flow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery. Rapid Commun Mass Spectrom 2006;20:1087-96
  • Ramanathan R, Zhong R, Blumenkrantz N, et al. Response normalized liquid chromatography nanospray ionization mass spectrometry. J Am Soc Mass Spectrom 2007;18:1891-9
  • Muster W, Breidenbach A, Fischer H, et al. Computational toxicology in drug development. Drug Discov Today 2008;13:303-10
  • Johnson DE, Rodgers AD. Computational toxicology: heading toward more relevance in drug discovery and development. Curr Opin Drug Discov Devel 2006;9:29-37
  • Dearden JC. In silico prediction of ADMET properties: how far have we come? Expert Opin Drug Metab Toxicol 2007;3:635-9
  • Khan MT, Sylte I. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules. Curr Drug Discov Technol 2007;4:141-9
  • Yin W, Mitra K, Stearns RA, et al. Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: Evidence for a mechanism involving nitroxide radicals and heme iron. Biochemistry 2004;43:5455-66
  • Zhang Z, Chen Q, Li Y, et al. In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinine type metabolites. Chem Res Toxicol 2005;18:675-85
  • Doss GA, Miller RR, Zhang Z, et al. Metabolic activation of a 1,3-disubstituted piperazine derivative: Evidence for a novel ring contraction to an imidazoline. Chem Res Toxicol 2005;18:271-6
  • Reddy VBG, Karanam BV, Gruber WL, et al. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. Chem Res Toxicol 2005;18:880-8
  • Tang C, Subramanian R, Kuo Y, et al. Bioactivation of 2,3-diaminopyridine-containing bradykinin B1 receptor antagonists: Irreversible binding to liver microsomal proteins and formation of glutathione conjugates. Chem Res Toxicol 2005;18:934-45
  • Singh R, Silva-Elipe MV, Pearson PG, et al. Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement and covalent binding to proteins. Chem Res Toxicol 2003;16:198-207
  • Chen H, Shockcor J, Chen W, et al. Delineating novel metabolic pathways of DPC 963, a non-nucleoside reverse transcriptase inhibitor, in rats. Characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC/MS and LC/NMR. Chem Res Toxicol 2002;15:388-99
  • Mutlib AE, Dickenson P, Chen SY, et al. Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates. Chem Res Toxicol 2002;15:1190-207
  • Hollenberg PF, Kent UM, Bumpus NN. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications. Chem Res Toxicol 2008;21:189-205
  • Kalgutkar AS, Obach RS, Maurer TS. Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions. Curr Drug Metab 2007;8:407-47
  • Masubuchi Y, Horie T. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs. Crit Rev Toxicol 2007;37:389-412
  • Manns MP, Obermayer-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease. Hepatology 1997;26:1054-66
  • Ju C, Uetrecht JP. Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. Curr Drug Metab 2002;3:367-77
  • Uetrecht J. Current trends in drug-induced autoimmunity. Autoimmun Rev 2005;4:309-14
  • Mitchell MD, Elrick MM, Walgren JL, et al. Peptide-based in vitro assay for the detection of reactive metabolites. Chem Res Toxicol 2008;21:859-68
  • Castro-Perez J, Plumb R, Granger JH, et al. Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. Rapid Commun Mass Spectrom 2005;19:843-8
  • Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007;47:513-39
  • Tirmenstein MA, Nelson SD. Subcellular binding and effects on calcium homeostasis produced by acetaminophen and a nonhepatotoxic regioisomer, 3′-hydroxyacetanilide, in mouse liver. J Biol Chem 1989;264:9814-9
  • Hansen BT, Jones JA, Mason DE, Liebler DC. SALSA: a pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses. Anal Chem 2001;73:1676-83
  • Dennehy MK, Richards KA, Wernke GR, et al. Cytosolic and nuclear protein targets of thiol-reactive electrophiles. Chem Res Toxicol 2006;19:20-9
  • Wong HL, Liebler DC. Mitochondrial protein targets of thiol-reactive electrophiles. Chem Res Toxicol 2008;21:796-804
  • Shin NY, Liu Q, Stamer SL, Liebler DC. Protein targets of reactive electrophiles in human liver microsomes. Chem Res Toxicol 2007;20:859-67
  • Liebler DC. Protein damage by reactive electrophiles: targets and consequences. Chem Res Toxicol 2008;21:117-28
  • Welch KD, Wen B, Goodlett DR, et al. Proteomic identification of potential susceptibility factors in drug-induced liver disease. Chem Res Toxicol 2005;18:924-33
  • Coen M, Lenz EM, Nicholson JK, et al. An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chem Res Toxicol 2003;16:295-303
  • Welch KD, Reilly TP, Bourdi M, et al. Genomic identification of potential risk factors during acetaminophen-induced liver disease in susceptible and resistant strains of mice. Chem Res Toxicol 2006;19:223-33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.